Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Cancer Type/Condition:  Liver cancer, adult primary
Stage/Subtype:  stage A adult primary liver cancer (BCLC)
Country:  U.S.A.
Trial Type:  Treatment
Results 1-16 of 16 for your search:
Start Over
Study of ThermoDox With Standardized Radiofrequency Ablation (RFA) for Treatment of Hepatocellular Carcinoma (HCC)
Phase: Phase III
Type: Treatment
Age: 18 and over
Trial IDs: 104-13-302, NCI-2014-02527, NCT02112656
Gemcitabine Hydrochloride and Cisplatin with or without Radiation Therapy in Treating Patients with Localized Liver Cancer That Cannot Be Removed by Surgery
Phase: Phase III
Type: Treatment
Age: 18 and over
Trial IDs: NRG-GI001, NCI-2014-00849, PNRG-GI001_A01PAMDREVW01, PNRG-GI001_A02PAMDREVW01, NCT02200042
PET/CT in Diagnosing Patients with Liver Cancer Undergoing Surgical Resection
Phase: Phase II
Type: Diagnostic, Treatment
Age: 18 and over
Trial IDs: RA-2011-025, NCI-2012-02095, CHS-19373, NCT01395030
Temsirolimus and Sorafenib Tosylate in Treating Patients With Stage II-IV Liver Cancer
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 to 85
Trial IDs: 124511, NCI-2012-02021, NCT01687673
Sorafenib Tosylate and Doxorubicin Hydrochloride in Treating Patients with Advanced Liver Cancer
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 12-259, NCI-2013-00867, NCT01840592
Doxorubicin-Eluting Beads in Treating Patients with Liver Cancer
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: J1306, NCI-2014-00341, CIR00005192, DEBDOX-M1, NA_00077927, NCT02007954
Chemoembolization with Doxorubicin Hydrochloride-Eluting Beads in Treating Patients with Liver Cancer Who Are Being Considered for Liver Transplant
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 124520, NCI-2015-00697, 082078, CC# 124520, DEB-TACE, UCSF CC#124520, NCT02147301
Yttrium Y 90 Glass Microspheres and Capecitabine in Treating Patients With Liver Cholangiocarcinoma or Liver Metastases
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: NU 08I5, NCI-2009-01122, STU00007062, NCT00858429
Oncolytic HSV-1 rRp450 in Treating Patients with Primary Liver Cancer
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 09-042, NCI-2010-01930, NCT01071941
Sorafenib Tosylate and Vorinostat in Treating Patients With Advanced Liver Cancer
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: MCC-12122, NCI-2010-00185, NCT01075113
Gemcitabine Hydrochloride, Floxuridine, and Dexamethasone after Surgery in Treating Patients with Liver Cancer That Can Be Removed by Surgery
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: Over 18
Trial IDs: 13-148, NCI-2013-01780, NCT01938729
Body Warming in Improving Blood Flow and Oxygen Delivery to Tumors in Patients With Cancer
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: I 229812, NCI-2013-01198, NCT01896778
Transarterial Chemoembolization With or Without Stereotactic Radiosurgery in Treating Patients With Liver Cancer Undergoing Liver Transplant
Phase: No phase specified
Type: Treatment
Age: 18 and over
Trial IDs: 16213, NCI-2014-00406, 818180, UPCC 16213, NCT01918683
Radiolabeled Glass Beads in Treating Patients with Liver Cancer That Cannot be Surgically Removed
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: OSU-10036, NCI-2012-00877, 2010C0053, NCT02072356
Transarterial Chemoembolization with Doxorubicin-Eluting Beads in Treating Patients with Liver Cancer That Cannot Be Removed by Surgery
Phase: No phase specified
Type: Treatment
Age: 18 and over
Trial IDs: 012014-079, NCI-2014-01192, 17393, NCT02141906
Start Over